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ABSTRACT: The mode of action of specific probiotic bacteria and  specific prebiotic ingredients and their
effects on the intestinal microbiota modulation in humans and animals has been demonstrated in many
studies. Intestine is characterized for harboring a complex and dynamic microbiota which, among others,
has a function to protect the host from inflammatory disorders. A mature and balanced endogenous
microbiota has also an important role in the maintenance of a desirable activity of the immune system.
Deviations in gut microbiota composition, due to improper diet, radiotherapy, antibiotic treatment, stress
and others, may lead to a variety of gastrointestinal disorders. To overcome an unbalanced microbiota,
the consumption of specific probiotics and prebiotics has been proved to be effective. For more than three
decades, many probiotic microorganisms have been characterized and evaluated. However, the term
prebiotic has only recently been identified, characterized and evaluated in human intervention studies.
The list of prebiotic ingredients remains limited, and yacon (Smallantus sonchifolia) is an Andean root to
which prebiotic attributes have been inferred recently. Humans and animals could seemingly benefit from
the consumption of specific prebiotics and probiotics.  In this work, terminology aspects of pre- and
probiotics, and their roles in human and animal health are discussed.
(Keywords:  probiotic; Bifidobacterium; prebiotic; yacon; animal health; human health)
CONCEPTO DE LA  TERMINOLOGÍA DE PROBIÓTICOS Y PREBIÓTICOS Y SU ROL
EN LA SALUD HUMANA Y ANIMAL
RESUMEN: Se ha demostrado en muchos estudios el modo de acción de las bacterias probióticas específicas
y de determinados ingredientes prebióticos y sus efectos en la modulación de la flora intestinal en humanos
y animales. El intestino se caracteriza por  hospedar una microbiota compleja y dinámica que, entre otras,
tiene  como función  proteger al huésped de trastornos intestinales. Una microbiota endógena madura y
equilibrada, también es importante para el mantenimiento de una actividad deseable del sistema
inmunológico. La perturbación de la microbiota intestinal puede tener un impacto en la fisiopatología de
una variedad de trastornos gastrointestinales. Para superar este desequilibrio  debido a la dieta,
radioterapia, terapias con antibióticos, situaciones de estrés y otros, se ha demostrado la eficacia del
consumo de probióticos y prebióticos específicos. Durante más de tres décadas, se han descrito y evaluado
muchos microorganismos probióticos; sin embargo, el término prebiótico sólo se ha identificado,
caracterizado y evaluado recientemente en estudios de intervención humana. La lista de ingredientes
prebióticos queda frenada y el yacón (Smallantus sonchifolia) es una raíz andina a la cual los atributos
prebióticos se han indicado recientemente. Los seres humanos y animales, aparentemente se  podrían
beneficiar  del consumo de prebióticos y probióticos especiales. En este trabajo se abordarán  los aspectos
de la terminología de pre y probióticos y su función en la salud humana y animal.
(Palabra  claves:  probiótico; Bifidobacterium; prebióticos; yacón; salud animal; salud humana)
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INTRODUCTION
Intestine is characterized for harboring a complex
and dynamic microbiota which, among others, has a
function to protect the host from intestinal disorders. A
mature and balanced endogenous microbiota, has also
an important role in the maintenance of a desirable
activity of the immune system. To overcome an
unbalanced microbiota, due to improper diet,
radiotherapy, antibiotic treatment, stress situations and
others, the consumption of specific probiotics and
prebiotics has been proved to be effective. Probiotics
are defined as «live microorganisms which when
administered in adequate amounts confer a health
benefit on the host» (1).Prebiotics are  defined as «non-
viable food component that confers a health benefit on
the host associated  to  microbiota» modulation (2).
Product containing probiotic (s) and prebiotic (s) is called
synbiotic.
For more than three decades, many probiotic
microorganisms have been described and evaluated.
However, the term prebiotic has only recently been
identified, characterized and evaluated in human
intervention studies. The list of prebiotic ingredients
remains l imited. The prebiotic activ it ies of
yacon(Smallantus sonchifolia),  originally an Andean
root,  have only been recently  studied (3) . Humans
and animals could seemingly benefit from the
consumption of specific probiotic and prebiotic.  Though
there are the numerous functions of pre- and probiotics
attributed to different health conditions in humans and
animals, the most studied are related to the modulation
of the intestinal microbiota.
In this work, the terminology of the main topics
related to pre- and probiotics, the main probiotic
organisms and prebiotic ingredients with emphasis in
yacon, as well as their roles in human and animal health
have been discussed.
Intestinal microbiota
Varieties of  organisms such as protozoa,
bacteriophage, fungi and bacteria are normal residents
of the gastrointestinal tract (GIT). From these, intestinal
bacteria are the most studied entity.  This microbiota
complies with more than 500 cultivable species (4)
achieving the highest densities not found in any other
studied ecosystem (5).  However, studies using modern
molecular techniques   have indicated that more than
1000 species are present in the gut. This complex
community is metabolically active and contributes to
homeostasis (6). The gut microbiota composition varies
with race, sex, age, diet and other factors (7). It
possesses key functions such as:
 i) fermentation of intestinal mucus produced by
epithelial cells (8), ii) metabolism of bilirubin,
cholesterol, bile acids, steroid hormones, pancreatic
enzymes, fatty acids (9, 10 ), iii) nutritional activity such
as providing the host with vitamins K and B (11) and
contributing to the protein homeostasis of the host via
synthesis of aminoacids,  iv) immune functions, acting
for example, in the stimulation of the innate and
adaptative immunity, aiding the host  to respond more
quickly to pathogen challenge (12, 13)  and v)
«colonization resistance», a  phenomenon characterized
namely by the resisting  of colonization of opportunistic
pathogens that preferentially overgrew  due to
inflammation or use of specific medications and broad-
spectrum  antibiotic (14).  When microbiota is disrupted,
the host becomes more susceptible to infections.  In
addition, antibiotic therapy af fects microbial
homeostasis, which can be recovered in a time period
as long as eight weeks after discontinuity of antibiotic
therapy (15). This situation leads to the potential use
of specific probiotics and prebiotics which act aiding to
a faster re-establishment of the normal intestinal
microbial community in the host gut. This microbial
community, estimated in 1014 cells, varies quantitatively
and qualitatively along with the different environments
from the stomach, small and large intestines and
outnumbers the total human eukaryotic cells (1013) (
16, 17).
Different habitats are encountered in the stomach,
small and large intestines, leading to a qualitative and
quantitative diversity of bacteria families, genera and
species.
Stomach microbiota. The numbers of the adapted
resident bacteria and fungi are controlled by the acidic
environment found in this habitat.  Among the described
genera usually found in the stomach are Actinomyces,
Fusobacterium, Peptostreptococcus,  Streptococcus,
Staphylococcus and Veillonella. The concentration of
microrganisms in the stomach  is low, barely reaching
levels of 103  CFU/g of gastric content  (16). As pH
increases along the gastrointestinal tract (GIT), the
microbial numbers increase.
Small intestine microbiota.  The small intestine
is a transitional zone between the stomach and the
colon. The presences of bile, pancreatic juices and
others, as well as the high rate of motility are among
the main variables responsible for controlling microbial
overgrowth in the small intestine. Facultative
microorganisms predominate and their numbers are in
the range of 104-108 CFU/g of the small intestine content
(12). The ileum harbours a transition microbiota, the
numbers of anaerobes increase and the presence of
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coliforms and species of the genera Bacteroides,
Fusobacterium and Lactobacillus is common. Bacterial
concentration in the ileum reaches 109 CFU/g (12).
Large intestine microbiota. Anaerobes
predominate in the large intestine of mammals. The
proximal colon is characterized by a high concentration
of substrates, a pH in the range of 5-6, and a rapid
microbial growth with accumulation of short chain fatty
acids (SCFA), while in the distal colon substrate is
less available, pH is close to neutrality and putrefactive
fermentation predominates (18). Colonic microbiota
consists of large numbers of anaerobes and the
presence of genera from the Enterobacteriaceae and
species of Enterococcus, Bacteroides, Fusobacterium,
Clostridium and Bifidobacterium is common (16,19).
The densities achieved reach concentrations up to 1011
to 1013 CFU/g of colonic content (20).
The faecal content has the highest concentration of
microorganisms, and bacteria comprise 33% of its dry
weight (7). Species belonging to Bacteroide, Clostridium
and Bifidobacterium genera have been found to
predominate in human faeces (21), whereas in rats,
the leading genera are Staphylococcus, Enterococcus,
Serratia and Proteus (22).
This diversity of pathogenic and saprophytic
microorganisms exists in equilibrium, and the
consumption of probiotics, prebiotics and synbiotics have
been considered potential alternatives to counteract its
disruption.
The concept of probiotic and probiotic-like
microorganism
Concerning and understanding  the concepts and
terminologies of functional foods including probiotic/
prebiotic/synbiotic have been materialized in a recent
publication (23). For the first time conceptual diagrams
depict probiotic and prebiotic from origin to labelling. With
the increasing of globalization, the terminology work in
specific areas is of utmost importance for economic and
scientific reasons. Knowing the possibilities of a probiotic
origin might help the search for new probiotic species in
similar ecological niches. It is also important to differentiate
a probiotic from a probiotic-like microorganism.  A probiotic
species is defined as «species of safe bacterium originated
from the host, mainly from the intestinal tract, and/or fungus
originated from plant which when administered in adequate
amounts confer a health benefit». Probiotic microorganism
refers to «safe bacterium originated from the host intestinal
tract which when administered in adequate amounts
confers a health benefit», and a probiotic-like
microorganism refers to safe bacterium and/or fungus
originated from other sources of the host intestinal tract
which when administered in adequate amounts confer a
health benefit» (23). Figure 1 indicates a conceptual relation
of these terms.
The most common probiotic microorganisms are
species belonging to the genera Lactobacillus and
Bifidobacterium for humans and Bacillus,
 
probiotic species 
* 
probiotic microorganism probiotic-like microorganism 
bacterium bacterium fungus 
Bifidobacterium
m  
Lactobacillus Bacillus Aspergillus Saccharomyce
s 
  B.animalis  
B. longum  
L. acidoph 
L. casei  B. coagulans  A. orizae  S. boulardii  
  B. infantis  L. rhamnosus  
B. breve  L.johnsonii 
L. acidophilus  
FIGURE 1. Diagram relating probiotic species, probiotic microorganism and probiotic-like microorganism. Adapted from
Magalhães et al. (23)./ Diagrama sobre especies de probióticos, microorganismos probióticos y microorganismos como
probióticos. Adaptado de Magalhães et al. (23) .
*Others
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Enterococcus, Lactobacillus, Aspergillus and
Saccharomyces for animals.
Probiotics are marketed in different formats (Fig. 2).
The main probiotic functions are indicated in figure 3.
The prebiotic concept
Natural defenses of human and animals could be
enhanced with the inclusion of functional foods into
human food and animal feed. Nowadays, the prebiotics
available are mainly carbohydrate in nature. They are
not metabolized at the upper intestine but rather by the
microbiota in the colon. Acting as main energy source,
prebiotics stimulate the growth of  benef icial
microorganisms such as bifibacteria; and for this reason
prebiotics were firstly known as bifidogenic factors. Also
other microbial groups might be stimulated as well.
This stimulus is followed by accumulation of
metabolites, mainly SCFA (acetate, butyrate, and
propionate) responsible for the maintenance of a
desirable dynamic microbiota and innate/specific
immune markers important for the host health.
Prebiotics currently marketed are disaccharide,
oligosaccharide and resistant starch in nature (Fig 4).
Inul in-type prebiotics are among the most
commercialized and studied prebiotics. Inulin and
fructooligosaccharides share this same nature.  They
are carbohydrates and, as such, are classified
according to their degree of polymerization, i.e.,
according to the number of monosaccharide units
combined.  They are also classified as non- digestible,
as the anomeric carbon atom (C1 or C2) of the
monosaccharide unit of the oligosaccharide has a
conf iguration that makes their osidic bonds
unsusceptible to the hydrolytic human enzymes.  Inulin
(3-60 sugar moieties) and fructooligosaccharides (3-20
sugar moieties) are linear â 2’!1 fructans which are
present in a variety of plants ( 24, 25 ).
 
      Probiotic product 
Probiotic food product Probiotic feed product 
 
Non food probiotic  product 
 
Liquid Solid 
 
Human/animal                      Human/animal 
Therapeutic adjunct              supplement 
 
 Fermented                Non fermented   Liquid Liquid 
Capsule Capsule 
Powder 
Pill 
Cream 
Ointment 
powder 
Supository 
Dry 
FIGURE 2. Formats of probiotic products generally marketed. Adapted from Magalhães et al. (23)./ Formatos de los
productos probióticos generalmente comercializados.
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Currently, many non-digestible oligosaccharides
(NDOs) are commercialized as food ingredients. They
are carbohydrates in which the monosaccharides unit
is glucose, galactose, fructose and xylose. Thirteen
commercialized types of NDO have been described:
i) cyclodextrin, i i ) f ructooligosaccharide,  i i i )
galactooligosaccharide, iv) gentiooligosaccharide, v)
glycosilsucrose, vi) isomaltooligosaccharide, vii)
lactosucrose, viii) lactulose, ix) maltooligosaccharide,
x) raf f inose,  xi ) soybeanoligosaccharide,
xylooligosaccharide (26).  Production processes of
some NDO are indicated on Table 1.
From the currently known NDO, the inulin-type
ingredients - inulin and fructooligosaccharides (FOS) -
are the most commercialized and studied. These
compounds have many important properties, making
them suitable alternatives in the process of balancing
a disturbed colon microbiota, thereby inhibiting many
undesirable diseases.
 
probiotic  
function 
 balance intestinal  
microbiota 
triglycerydes 
cholesterol 
 
   allergy 
    symptoms 
 
   colon 
    cancer risk  
 
   bowel  inflamation calcium/other 
mineral absorption 
 immue response  Pathogen antagonism 
FIGURE 3.  The main probiotic functions./ Principales funciones de los probióticos. 
Prebiotic source/origin 
/originsource/origin 
Oligosaccharide Disaccharide Resistant starch 
   Lactulose 
/originsour
Lactitol 
/origins
     Xylitol 
/originsourc
Fructo-oligosaccharide (FOS) 
xylitol /originsource/origin 
  Galacto-oligisaccharide 
(GOS) (GOS)xylitol 
  Inulin 
/originsourc
 Xylo-oligosaccharide 
/originsource/origin 
 Soybean-oligosaccharide 
FIGURE 4.  Prebiotic origin. Adapted from Magalhães et al. (23)./ Origen de los probióticos.
Adaptado de Magalhães et al. (23).
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A summary of the main benefits imparted to the
consumption of prebiotics is indicated in Figure 5.
Many of the functions of prebiotics are part of the
portfolio of probiotic functions, as the promoter of such
benefits relies in the modulated microbiota (fig. 4 and 5).
Nowadays, commercial FOS are mainly originated
from extraction/hydrolysis of Jerusalem artichoke and
chicory. However, recently renewed interest has been
directed to a rediscovered crop from the Andes, the
yacon (Smallanthus sonchifolius), which  harbors a
much higher concentration of FOS.  In this fruit-like
root sugar FOS is stored instead of starch. Yacon is
so rich in FOS that «an effective prebiotic dose can be
achieved by only consuming the root in moderate
amounts»(27 ).  To date, most of the yacon studies are
upon its antidiabetic effect (28). Other studies indicated
that colonic transit was ameliorated in volunteers (29),
positive effect was detected on calcium/magnesium
balance and bone calcium retention in rats (30) and
that no adverse effect on rats was detected through an
oral toxicity evaluation (31). Important finding is the
potential of yacon to be used as prebiotic and to control
obesity and insulin resistance in humans (32).  The
richness of the yacon in bio-ingredients and functionality
has recently been highlighted as it has been indicated
as novel food candidate to the EU market (27). Therefore
it is important that more clinical studies be undertaken
to clarify the mechanistic effect of yacon consumption
as this functional food might have an important role in
public health to mitigate the effects of a number of
chronic conditions affecting the growing aging
population.
TABLE 1.  Production processes of some non digestible oligosaccharides (NDO)./ Procesos de producción de algunos 
oligosacáridos no digeribles (NDO) 
 
Raw material Method/Reaction Main Carbohydrate Reaction/Method NDO 
Inulin Hydrolysis - - Fructooligosaccharide 
Extraction - - Raffinose Beet 
Extraction Sucrose Transglycosilation Isomaltulose 
Extraction Lactose Isomerization Lactulose Cow’s milk 
Extraction Lactose Transglycosilation Galactooligosaccharide 
Starch Hydrolysis Soluble Starch Transglycosilation Cyclodextrin 
 Hydrolysis Soluble Starch Hydrolysis Maltooligosaccharide 
 Hydrolysis +  
Transglycosylation 
Soluble Starch Hydrolysis Isomaltooligosaccharide 
Soybean Extraction Soluble Starch Extraction Soybean oligosaccharide 
Xylan hydrolysis - - xylooligosaccharides 
Adapted from Sako et al. (26) 
 
 
Prebiotic  
function 
 Faeces 
Output 
 
Triglycerydes 
cholesterol 
 
   Caloric 
    value 
 
   Colon 
    cancer risk  
 
  Desirable 
microbiota in colon  
 
Calcium/other 
mineral absorption 
 Immue response  Folate/B vitamins 
FIGURE 5. The main prebiotic functions./  Principales funciones de los prebióticos.
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Health  effect of probiotics and prebiotics
There is an  increasing evidence that pro- and
prebiotics can play a role in alleviating some diseases
and conditions as summarized in figures 4 and 5. It is
important, however, to highlight that almost all of these
effects rely on the beneficial modulation of the intestinal
microbiota and in the increasing importance that pro-
and prebiotics have in the modulation of different types
of diarrhea, as they represent «supportive therapy for
conditions established by the disruption of the normally
protective microbiota» (14).
In animal husbandry and management, pro- and
prebiotics are emerging as important tools to fight
microbial unbalance mainly during stress conditions.
Reductions in pathogenic and increases in desirable
intestinal bacteria can result in local and systemic
immune activation, rendering  animals healthier and
increasing their performance.
Promising results have been found upon
administration of probiotics in swine, poultry, cattle and
sheep. The surge in popularity of the application of
probiotic in the agriculture industry relies basically upon
its potential for livestock growth promotion especially
after the 2006 EU-wide ban on in-feed antibiotic growth
enhancers. The physiological state of animals
influences their performance (33).  In swine, the weaning
period has a great economic impact due to the common
occurrence of intestinal disorders, and this transition
time is characterized by changes in the feeding
procedure and in the relation of the siblings with the
sows. Furthermore, this separation at an early age
(usually 21 days), coupled with an immature intestine,
exacerbate animal stress. At this stage, a probiotic
function such as barrier, competitively excludes
pathogens. This mechanism is also promising in animals
after treatment with antibiotics, mainly in the prevention
of Salmonella infection. In previous studies, body weight
was improved upon supplementation of weaned pigs
with Lactobacillus sobrius and challenged with E. coli
K88 (34). In another report, E. faecium and   E. faecalis
have been used in several clinical trials, albeit not
proposed by QPS (35). Baum and colleagues found
that sows´ diet supplemented with Enterococcus
faecium protected one week post weaned piglets from
diarrhea.  They also reported that weaned pigs had
improved growth after 4 months of feed consumption
containing Saccharomyces boulardii (36).
 The main stressors in broiler production are related
to post hatching, transportation and stocking densities
(37). The poultry intestinal microbiota seems to have
an effect on growth, egg production and feed conversion,
and probiotic use is directed to maintain the health
state by enhancing the competitive exclusion (CE) of
pathogens (38). The term Competitive Exclusion is also
known as the Nurmi concept, and has originated from
the observation that Salmonella was inhibited when the
infected bird was fed with a suspension containing gut
material from a healthy adult chicken (39).  The CE is
seen as a main alternative to maintain a healthy gut in
poultry studies. An artif icially infected hatchery
experiment with Salmonella enteriditis (104 CFU)
indicated that chicks receiving doses of Lactobacillus
FM-B11 (106-8 CFU) were protected from the infection
(40). Natural antibodies for some antigens was increased
in  serum and gut of chicks following ingestion of a mix
of Lactobacillus acidophilus, Bifidobacterium bifidum
and Enterococcus faecalis (41). Probiotics are a good
strategy to maintain pathogens at bay, thus protecting
the gut microbiota of poultry and other production
animals. Although prebiotic use in this area is quite
new, conflicting results have already been reported (42).
Comprehensive reviews on these subjects are indicated
elsewhere (43, 17, 27).
Considering  that probiotics and prebiotics are part
of functional foods, it is important to remember the main
features for the maintenance of such ingredients within
that classification are basically twofold: i) to be
consumed  with the normal, everyday diet, ii) have a
positive effect on target function(s) that may enhance
well-being and health, and/or reduce the risk of disease.
CONCLUSION
Within the last decade, studies on the relationship
of human/ animal gut microbiota and immunology have
shed light to the role of probiotics and prebiotics on the
health of mammals.  Evidences exist pertaining the
influence that pro-, pre- and synbiotics have in the
microecology of the intestines of human and animals,
and their role in alleviating various diseases. Microbial
ecology coupled with the understanding of the human
genome have «paved the path for the clarifying of the
mechanisms involved with the health effects of probiotics
and prebiotics» (44).  Because of the large amount of
evidence and diversity of the beneficial effects of these
functional foods/ingredients, presently their potential
could be considered underestimated. The contingent
of individuals aged 65 or older is increasing globally,
which constitutes a public health concern. Functional
foods are now part of the modern thinking based on
prevention and/or alternatives for decreasing the risk
associated to chronic diseases. Furthermore, the
concerning of maintaining «cleaner» feeds to curb
dysbiosis in humans and animals has increased the
use of pro- and prebiotics for the promotion of livestock
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growth, specially after the 2006 EU-wide ban on in-
feed antibiotic growth enhancers. Probiotic, prebiotic
and synbiotic food, feed supplements and ingredients
abound the market, albeit confirmation of the benefits
and mechanisms of action still remains mostly putative.
Still, they constitute important tools to help maintaining
humans and animals in good health.
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